Interventional Cardiology Devices | Market Insights | Japan | 2023
Despite the negative impact of the COVID-19 pandemic in the short term, the Japanese IC device market will grow minimally through 2031, driven by aging population and expanding CAD patient pool, the growing prevalence of complex lesions and the emergence of specialized premium-priced technologies to diagnose and treat these complex CADs—such as next-generation DES, BRS, and intravascular imaging catheters and pressure guidewires—supporting revenues. However, revenues will be hindered by eroding ASPs due to biennial reimbursement cuts by the MHLW over the forecast period, particularly in the mature PTCA balloon catheter and coronary stent segments, resulting in overall market contraction over the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IC devices in Japan, with market projections from 2019 through 2031.
